|
|
Volumn 255, Issue SUPPL.3, 2008, Pages 1-2
|
|
Advances in the use of IVIg in neurological disorders
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOGLOBULIN;
PLACEBO;
ALZHEIMER DISEASE;
ANAPHYLAXIS;
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DIABETIC NEUROPATHY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
HEADACHE;
HEART INFARCTION;
HUMAN;
INFLAMMATION;
KIDNEY FAILURE;
LONG TERM CARE;
MULTIPLE SCLEROSIS;
MYALGIA;
NARCOLEPSY;
NAUSEA;
NEUROLOGIC DISEASE;
PARANEOPLASTIC NEUROPATHY;
PATIENT MONITORING;
PRIORITY JOURNAL;
STROKE;
AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM;
DRUG TOXICITY;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
INFLAMMATION;
NERVOUS SYSTEM DISEASES;
PATIENT SELECTION;
POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;
TREATMENT OUTCOME;
|
|
EID: 49249125334
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-3001-1 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (5)
|
